From: Genetic diversity of msp3α and msp1 _b5 markers of Plasmodium vivax in French Guiana
Patient | Time between episodes | msp3α allele | msp1_b5 allele | Interpretation |
---|---|---|---|---|
R001 | A1 | SAL-1 H | ||
R001 | 18 days | C | H2C | New Infection or Relapse from Heterologous Hypnozoites |
R002 | C+A | SAL-1 H | ||
R002 | 6 months | C | H2C | New Infection or Relapse from Heterologous Hypnozoites |
R003 | C | SAL-1 H | ||
R003 | 1 month 20 days | C | SAL-1 H | Traitment failure or Relapse from homologous hypnozoites |
R004 | A1 | SAL-1 I | ||
R004 | 2.5 months | A7 | H1A | New Infection or Relapse from Heterologous Hypnozoites |
R005 | C | SAL-1 H | ||
R005 | 5.5 months | C | SAL-1 E | New Infection or Relapse from Heterologous Hypnozoites |
R006 | C | SAL-1 H | ||
R006 | 1 month 12 days | C | SAL-1 H | Traitment failure or Relapse from homologous hypnozoites |
R006 | 5 months | C | SAL-1 B | New Infection or Relapse from Heterologous Hypnozoites |
R007 | A2 | SAL-1 B | ||
R007 | 1.5 month | A2 | SAL-1 B | Traitment failure or Relapse from homologous hypnozoites |
R008 | A4 | SAL-1 E | ||
R008 | 1 month 5 days | A4 | SAL-1 E | Traitment failure or Relapse from homologous hypnozoites |
R009 | C | H 1C | ||
R009 | 1.5 month | C | H 1C | Traitment failure or Relapse from homologous hypnozoites |
R010 | A7 | Belem 5 | ||
R010 | 28 days | A7 | Belem 5 | Traitment failure or Relapse from homologous hypnozoites |